论文部分内容阅读
据目前进行的癌症和类固醇激素研究表明,妇女每日服用雌激素/孕甾酮的复合避孕药12个月或更长时间,能减少患子宫内膜癌的危险性50％。这种作用可持续15年之久,可防止三种主要组织学亚型的恶性子宫内膜癌:腺癌、腺棘皮癌和腺鳞癌。上述发现来自迄今最大的病例系列研究,证实了较早的报告所提出的事实:口服避孕药(OC)能预防子宫内膜癌,特别是对35岁以下、不吸烟的非经产妇女。在JAMA(Feb.13,1987)发表的报告首次证明OC有预
According to ongoing cancer and steroid hormone studies, women who take estrogen / progesterone daily for 12 months or longer can reduce the risk of endometrial cancer by 50%. This effect lasts for 15 years and prevents malignant endometrial cancer in three major histological subtypes: adenocarcinoma, adenocarcinoma, and adenosquamous carcinoma. The above findings come from the largest series of case studies to date, confirming the earlier report’s suggestion that oral contraceptives (OCs) prevent endometrial cancer, especially for non-pregnant women under the age of 35 who do not smoke. The report published in JAMA (Feb.13, 1987) shows for the first time that OC is available